Early BNP and cGMP Surge After Heart Attack Predicts Better Heart Recovery
In patients with anterior heart attacks, early activation of the BNP-cGMP signaling cascade independently predicted favorable heart remodeling and fewer major cardiac events over nearly 10 years of follow-up.
Quick Facts
What This Study Found
ProBNP and estimated mature BNP from 12 hours to 5 days post-AMI, and cGMP from immediately post-intervention to 3 days, were independent predictors of left ventricular reverse remodeling.
Key Numbers
67 patients with first anterior AMI. Median age 64 years, 76% male. Measured BNP-cGMP cascade components prospectively.
How They Did This
Prospective cohort study of 67 anterior AMI patients with serial blood sampling of ANP, BNP molecular forms, and cGMP from immediately post-PPCI through 10 months, with cardiac MRI assessment and median 9.9-year clinical follow-up.
Why This Research Matters
Natriuretic peptides are usually viewed as passive markers of heart failure severity. This study suggests they may actually drive cardiac recovery after a heart attack — shifting the narrative from BNP as a diagnostic tool to BNP as a therapeutic pathway worth enhancing.
The Bigger Picture
This study adds to growing evidence that natriuretic peptides are not just biomarkers but active participants in cardiac repair. If the BNP-cGMP axis can be therapeutically augmented early after a heart attack — through drugs like sacubitril that prevent BNP breakdown — it might improve long-term heart recovery outcomes.
What This Study Doesn't Tell Us
Small sample size (67 patients) from a single center limits generalizability. The study is observational and cannot prove that BNP-cGMP activation causes reverse remodeling. The median split for defining LVRR groups is somewhat arbitrary. The cohort was predominantly male (76%).
Questions This Raises
- ?Could administering neprilysin inhibitors (sacubitril) early after heart attack enhance protective BNP-cGMP signaling?
- ?Do patients with genetically higher BNP production have better cardiac recovery after AMI?
- ?Can early cGMP measurement be added to routine post-AMI risk stratification?
Trust & Context
- Key Stat:
- 74% lower MACCE risk Patients with left ventricular reverse remodeling had a 74% lower risk of major cardiac and cerebrovascular events over nearly 10 years of follow-up (HR 0.256).
- Evidence Grade:
- This is a prospective cohort study with nearly 10 years of follow-up and rigorous serial biomarker measurement. However, the small sample size (n=67) and single-center design limit the evidence strength.
- Study Age:
- Published in 2025, based on a long-term prospective cohort with median 9.9-year follow-up.
- Original Title:
- Association between left ventricular reverse remodelling and the B-type natriuretic peptide-cGMP cascade after anterior acute myocardial infarction.
- Published In:
- Open heart, 12(1) (2025)
- Authors:
- Arai, Marina, Asaumi, Yasuhide, Honda, Satoshi, Ogata, Soshiro, Kiyoshige, Eri, Nakao, Kazuhiro, Miura, Hiroyuki, Morita, Yoshiaki, Nakashima, Takahiro, Murai, Kota, Iwai, Takamasa, Sawada, Kenichiro, Matama, Hideo, Fujino, Masashi, Takahama, Hiroyuki, Yoneda, Shuichi, Takagi, Kensuke, Otsuka, Fumiyuki, Kataoka, Yu, Nishimura, Kunihiro, Noguchi, Teruo, Minamino, Naoto, Yasuda, Satoshi
- Database ID:
- RPEP-09963
Evidence Hierarchy
Frequently Asked Questions
Is BNP good or bad after a heart attack?
This study suggests early BNP activation may actually be protective. While high BNP is traditionally seen as a sign of heart stress, the BNP-cGMP signaling cascade appears to promote beneficial cardiac remodeling — meaning the heart recovers rather than continues to deteriorate.
What is left ventricular reverse remodeling?
After a heart attack, the heart can either progressively enlarge and weaken (adverse remodeling) or recover toward a more normal size and function (reverse remodeling). Patients who achieve reverse remodeling have much better long-term outcomes.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09963APA
Arai, Marina; Asaumi, Yasuhide; Honda, Satoshi; Ogata, Soshiro; Kiyoshige, Eri; Nakao, Kazuhiro; Miura, Hiroyuki; Morita, Yoshiaki; Nakashima, Takahiro; Murai, Kota; Iwai, Takamasa; Sawada, Kenichiro; Matama, Hideo; Fujino, Masashi; Takahama, Hiroyuki; Yoneda, Shuichi; Takagi, Kensuke; Otsuka, Fumiyuki; Kataoka, Yu; Nishimura, Kunihiro; Noguchi, Teruo; Minamino, Naoto; Yasuda, Satoshi. (2025). Association between left ventricular reverse remodelling and the B-type natriuretic peptide-cGMP cascade after anterior acute myocardial infarction.. Open heart, 12(1). https://doi.org/10.1136/openhrt-2024-002927
MLA
Arai, Marina, et al. "Association between left ventricular reverse remodelling and the B-type natriuretic peptide-cGMP cascade after anterior acute myocardial infarction.." Open heart, 2025. https://doi.org/10.1136/openhrt-2024-002927
RethinkPeptides
RethinkPeptides Research Database. "Association between left ventricular reverse remodelling and..." RPEP-09963. Retrieved from https://rethinkpeptides.com/research/arai-2025-association-between-left-ventricular
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.